Purchase Order HHSN261201600010A
Award Date 7/29/16
Potential Completion Date 7/28/17
Potential Value $374K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27713, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Metabolon, Inc., a self-certified small disadvantaged business. The $124,800 contract is for a project titled "The Effect of Pre-Analytical Conditions on Metabolite Stability in Urine." Metabolon is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $994,520 contract is for dietary biomarker development work in support of three NCI-funded studies: the Interactive Diet and Activity Tracking in AARP (IDATA) Study, the Women's Alcohol Study (WAS), and the Golestan Cohort Study (GCS). This award supports Metabolon's specialized metabolomics analysis...
- This federal contract award, valued at $171,720.00, was issued by the National Cancer Institute (NCI) to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for the acquisition of laboratory services to support research on the associations of fecal metabolites with body mass index and colorectal cancer, involving the analysis of 611 samples. Metabolon is a leading provider of specialized metabolomics analysis services, leveraging its proprietary technology platforms...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a Firm Fixed Price Delivery Order contract to Metabolon, Inc., a self-certified small disadvantaged business and for-profit organization, to provide metabolomics analysis services for a nested case-control study of lipidomics and pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study...
- This is a firm fixed-price delivery order contract awarded to Metabolon, Inc., a self-certified small disadvantaged business, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The contract, valued at $12,000.00, is for a pilot study to analyze bile acid and short-chain fatty acid panels. This work supports the NCI's Metabolomic Profiling for Molecular Epidemiology Studies program, which leverages advanced metabolomics techniques to gain insights into...
- This is a $112,030.00 firm-fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for a prospective investigation of microbial metabolites, bile acids, and short-chain fatty acids in relation to colorectal cancer, as part of the ATBC Prevention Study. The work will be performed in Durham, North Carolina. Metabolon provides...
- The National Cancer Institute awarded a $146,900.04 firm fixed-price purchase order contract to Metabolon, Inc., a self-certified small disadvantaged business, to provide services to measure metabolomics markers related to pancreatic cancer in human serum samples. The contract has a completion date of January 31, 2017 and was not set aside. Metabolon, Inc. is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on numerous federal contracts and...
- This is a $94,500.00 time and materials contract awarded by the National Cancer Institute (NCI) to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for Task Order 13 under the METABOLOMIC PROFILING FOR MOLECULAR EPIDEMIOLOGY STUDIES program to provide metabolomic assays in support of the CONNECT Methods Study. This contract does not have a set-aside designation. Metabolon, Inc. is an experienced federal contractor that has received multiple awards from agencies...
- The Department of Health and Human Services, National Cancer Institute awarded a $177,500.00 firm fixed price purchase order contract to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic research and serum sample analysis in pancreatic cancer. The contract has an ultimate completion date of September 15, 2018 and was awarded on September 16, 2016. Metabolon is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on...
- This firm fixed price delivery order, valued at $280,500.00, was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Metabolon, Inc. for the "PROSPECTIVE SERUM METABOLOMIC PROFILE OF PROSTATE CANCER IN THE ATBC STUDY" with a period of performance from June 27, 2017 to September 26, 2017. Metabolon, a self-certified small disadvantaged business, is a leading provider of metabolomics solutions and has served as a prime...